Thus, IGF-1 and cytokine IL-8 may be considered as a novel and efficient therapeutic strategy for myocardial infarction in humans by enhancing angiogenesis, leading to chronic improvement in cardiac function. The gene discussed is CXCL8; the disease is myocardial infarction.